Typewriter Therapeutics
Cambridge, US · Founded 2022 · 1 known investors
Find your way into Typewriter Therapeutics
Founders & leadership
MS
Matthew StantonNamed on SEC filing
KH
Kenneth HorneNamed on SEC filing
MD
Mikael DolstonNamed on SEC filing
Board
LT
Laura TadvalkarBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$56.3MraisedSep 2026 · 6 investors · BiotechnologyRule 506(b)
▶$56.3MraisedSep 2026 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew StantonExecutive Officer, Director
- Kenneth HorneDirector
- Laura TadvalkarDirector
- Mikael DolstonDirector
- Offering amount
- $56.3M
- Amount sold
- $56.3M
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Typewriter Therapeutics's investors?
- Typewriter Therapeutics's investors include RA Capital.
- Where is Typewriter Therapeutics headquartered?
- Typewriter Therapeutics is headquartered in Cambridge, US.